News & Articles

Seven years after being diagnosed with Leigh syndrome, Asher Times is defying the odds — walking, talking, eating, and attending school in a mainstream classroom — thanks to the specialized care he’s received from Mary Kay Koenig, MD, director of the Center for the Treatment of Pediatric Neurologic and Neurodegenerative Disease at McGovern Medical School at UTHealth Houston.

Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a promising avenue to treat cancer, according to new research by UTHealth Houston.

Researchers at UTHealth Houston have been awarded three grants totaling more than $5 million from the National Institutes of Health and the National Science Foundation (NSF) to address one of the biggest challenges in modern health care: building enhanced data resources and technologies to accelerate scientific discovery and improve decision-making in medicine.

A study from the lab of Faraz Bishehsari, MD, PhD, professor in the Department of Internal Medicine at McGovern Medical School at UTHealth Houston, and director of the Gastroenterology Research Center, seeking to develop new methods to personalize treatment for pancreatic ductal adenocarcinoma, has been funded by the National Institutes of Health.